What ails Divi’s?
Finshots Daily
00:00
Is Devi's a Great Buy?
Devi's is gearing up to meet the demand for drugs that will soon go off-patent in the next three years. At one point, the stock was trading at 50 times its earnings. Even a small hurdle can skewer the share price. The business is probably still solid, but investors ran ahead of themselves.
Play episode from 06:56
Transcript
